JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate
Clinical significance of the JAK2V617F mutation in patients with a myeloproliferative neoplasm has been the target of intensive research in recent years. However, there is considerably uncertainty about prognosis in JAK2V617F positive individuals without overt signs of myeloproliferative disease. In...
| Príomhchruthaitheoirí: | , , , , |
|---|---|
| Formáid: | Alt |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
Ferrata Storti Foundation
2014-09-01
|
| Sraith: | Haematologica |
| Rochtain ar líne: | https://haematologica.org/article/view/7137 |